10x Genomics Inc.
(TXG) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
16.01
0.50%
After-hours Jan 06, 2025, 05:19 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | -255.10M | -166.00M | -58.22M | -542.73M | -31.25M | -112.48M | -18.76M |
Depreciation & Amortization | 43.62M | 33.01M | 28.25M | 19.02M | 7.07M | 3.90M | 4.30M |
Stock-Based Compensation | 166.95M | 136.85M | 95.96M | 48.63M | 13.33M | 2.66M | 1.66M |
Other Working Capital | 26.10M | -5.13M | -34.36M | -10.16M | 51.85M | 43.91M | 6.04M |
Other Non-Cash Items | 11.99M | 1.96M | 79.00K | 306.02M | 101.00K | 1.25M | 149.00K |
Deferred Income Tax | n/a | n/a | n/a | 1.55M | 614.00K | 251.00K | n/a |
Change in Working Capital | 17.34M | -39.42M | -87.44M | -50.38M | 44.76M | 28.02M | 1.95M |
Operating Cash Flow | -15.20M | -33.61M | -21.37M | -217.90M | 34.63M | -76.41M | -10.70M |
Capital Expenditures | -49.52M | -131.66M | -101.28M | -38.39M | -42.77M | -6.71M | -3.76M |
Acquisitions | n/a | -4.00M | -5.45M | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -282.87M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 183.02M | 67.64M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -923.00K | -215.23M | n/a | -1.73M | -25.00K | -425.00K | n/a |
Investing Cash Flow | 133.49M | -350.89M | -106.73M | -38.39M | -42.77M | -6.71M | -3.76M |
Debt Repayment | n/a | n/a | n/a | -37.10M | n/a | 18.74M | -393.00K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -80.00K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.67M | 15.82M | 35.30M | 23.74M | 3.77M | 86.63M | 21.06M |
Financial Cash Flow | 13.67M | 15.82M | 35.30M | 468.91M | 414.59M | 105.37M | 20.58M |
Net Cash Flow | 131.93M | -368.72M | -92.57M | 212.15M | 406.40M | 22.23M | 6.11M |
Free Cash Flow | -64.72M | -165.27M | -122.65M | -256.29M | -8.14M | -83.12M | -14.46M |